Physician profile
Michelle M Davis
NPI 1265852651
$2,062.56
in general payments reported to CMS, 2019-2025
24 companies · $630 in 2025
The $630 reported for 2025 was more than what 78% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $288 · 2022: $295 · 2023: $516 · 2024: $334 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455 · Grant: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.83 |
| Grant | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $349.28 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $305.78 | 2024-2025 | Indigo System |
| Silk Road Medical, INC. | $286.13 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cardiva Medical, INC. | $155.46 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Janssen Pharmaceuticals, INC | $121.31 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $112.39 | 2023-2025 | Enroute Transcarotid Neuroprotection System, Varithena Administration Pack, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $102.78 | 2021 | |
| Sanofi-Aventis U.S. LLC | $100.00 | 2022 | |
| Abbott Laboratories | $89.57 | 2025 | Esprit, Emboshield Nav6, Diamondback Peripheral |
| Organogenesis INC. | $84.14 | 2023 | Puraply Antimicrobial |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.79 | 2021 | |
| Ethicon US, LLC | $44.50 | 2022-2023 | Surgicel Nu-Knit, Evarrest |
| Medtronic, INC. | $33.53 | 2021-2022 | |
| Integra Lifesciences Corporation | $28.69 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $27.27 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $23.61 | 2021 | |
| Haemonetics Corporation | $20.38 | 2025 | Teg6s Hemostasis System |
| Arjo INC. | $17.89 | 2024 | |
| Smith+Nephew, INC. | $17.77 | 2023 | Renasys Touch, Pico 14, Renasys Go V2 Home |
| Lemaitre Vascular, INC. | $16.76 | 2023 | Artegraft Vascular Graft |
| Actelion Pharmaceuticals US, INC. | $13.61 | 2023 | Opsumit, Uptravi |
| Argon Medical Devices, INC. | $12.81 | 2022 | |
| Merck Sharp & Dohme LLC | $12.41 | 2021 | |
| Aroa Biosurgery Incorporated | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.